cvs 2

278
CARDIOVASCULAR SYSTEM Dr. Atifa Shuaib Associate Professor of Pathology Rawalpindi Medical College

Upload: rawalpindi-medical-college

Post on 11-May-2015

696 views

Category:

Documents


6 download

DESCRIPTION

patho

TRANSCRIPT

Page 1: Cvs 2

CARDIOVASCULAR SYSTEMDr. Atifa Shuaib

Associate Professor of Pathology

Rawalpindi Medical College

Page 2: Cvs 2
Page 3: Cvs 2
Page 4: Cvs 2
Page 5: Cvs 2
Page 6: Cvs 2
Page 7: Cvs 2
Page 8: Cvs 2
Page 9: Cvs 2

CARDIOVASCULAR SYSTEM

Diseases of Blood vessels

Diseases of Heart

Page 10: Cvs 2

Diseases of blood vessels

Congenital anomalies

Arteriosclerosis

Hypertensive vascular disease

Aneurysms & Dissections

Vasculitis

Tumors

CARDIOVASCULAR SYSTEM

Page 11: Cvs 2

ARTERIOSCLEROSIS:

Atherosclerosis

Monckeberg medial calcific sclerosis

Arteriolosclerosis

CARDIOVASCULAR SYSTEM

Page 12: Cvs 2

Fatty streaks Aortas of children

Risk factors Atheroma in adults

↓ ↓

Ischaemic Heart Disease

CARDIOVASCULAR SYSTEM

Page 13: Cvs 2

ATHEROSCLEROSIS

CARDIOVASCULAR SYSTEM

Page 14: Cvs 2

RISK FACTORS:

Non Modifiable

Modifiable

CARDIOVASCULAR SYSTEM

Page 15: Cvs 2

NONMODIFIABLE:Age:

advancing ageSex:

males > femalespostmenopausal risk equal

Genetics:familial predisposition

CARDIOVASCULAR SYSTEM

Page 16: Cvs 2

MODIFIABLE:

Hyperlipidemia:

hypercholesterolemia

LDL (bad cholesterol)

HDL (good cholesterol)

↓ by exercise

↑ by obesity & smoking

CARDIOVASCULAR SYSTEM

Page 17: Cvs 2

Diet

↑ cholesterol egg yolk, butter, animal fat

↓ cholesterol omega 3 FA

Statins ↓ cholesterol

CARDIOVASCULAR SYSTEM

Page 18: Cvs 2

CARDIOVASCULAR SYSTEM

Page 19: Cvs 2

CARDIOVASCULAR SYSTEM

Page 20: Cvs 2

Hypertension:>169/95 mm Hg 5 fold ↑ risk

Smoking:200% ↑ death rate

Diabetes Mellitis:hypercholesterolemiatwice ↑ risk MIgangrene lower limbs (200% risk)

CARDIOVASCULAR SYSTEM

Page 21: Cvs 2

Others:homocystinuriainflammationlipoprotein a (Lp a)lack of exercisestressful lifetype A personalityobesity

CARDIOVASCULAR SYSTEM

Page 22: Cvs 2

Multiple risk factors Multiplicative effect

CARDIOVASCULAR SYSTEM

Page 23: Cvs 2

participants had increases in HDL cholesterol averaging about 2.5 mg/dL. This increase in HDL cholesterol was only modest, but was statistically significant. Furthermore, since cardiac risk is thought to drop by two to three percent for each 1 mg/dL increase in HDL, a 2.5 mg/dL rise in HDL amounts to a substantial reduction in risk.

Page 24: Cvs 2

Exercise is involved in increasing the production and action of several enzymes that function to enhance the reverse cholesterol transport system (Durstine & Haskell 1994). The precise mechanisms are unclear, but evidence indicates that other factors including diet, body fat, weight loss, and hormone and enzyme activity interact with exercise to alter the rates of synthesis, transport and clearance of cholesterol from the blood (Durstine & Haskell 1994).

Page 25: Cvs 2

PATHOGENESIS:

“response to injury hypothesis”

A disease of intima

Chronic inflammation of arterial wall in

response to injury to endothelium

CARDIOVASCULAR SYSTEM

Page 26: Cvs 2
Page 27: Cvs 2

Chronic endothelial injury activation Accumulation of lpoproteins (LDL) Oxidation of LP Monocyte migration macrophage

accumulation Foam cells

CARDIOVASCULAR SYSTEM

Page 28: Cvs 2

Platelet adhesion Chemical mediator release Smooth muscle cells migration SMCs proliferation ECM deposition Lipid accumulation

CARDIOVASCULAR SYSTEM

Page 29: Cvs 2

CARDIOVASCULAR SYSTEM

Page 30: Cvs 2

1. Endothelial injury (repetitive):endothelial dysfunction ? injuryrepetetive non denudingtoxins, chemical mediators, infectionshemodynamic disturbance sites of ostia and bifurcationposterior wall of abdominal aortahypercholesterolemia

CARDIOVASCULAR SYSTEM

Page 31: Cvs 2

2. Inflammation (chronic):initiation - complicationsendothelial cell adhesion moleculesVCAM-1monocyte adhesion & migrationmacrophage accumulation in intimafoam cell formationIL-1, TNFMCP-1

CARDIOVASCULAR SYSTEM

Page 32: Cvs 2

Macrophages toxic oxygen species oxidation of lipids GF smooth muscle cell proliferationT lymphocytes cellular & humoral

3. Lipids:cholesterol & its esters in atheromasOxidized LDL in macrophages

CARDIOVASCULAR SYSTEM

Page 33: Cvs 2

genetic defects hypercholesterolemia AS

MI at young age with ↑ cholesterol

DM, hypothyroidism ↑ cholesterolAS

high cholesterol diet AS

severity of AS levels of cholesterol

↓ing cholesterol levels risk of AS ↓

CARDIOVASCULAR SYSTEM

Page 34: Cvs 2

Mechanism :1. Chronic hyperlipidemia EC activation2. Chronic hyperlipidemia LP accumulate in intima3. Oxidized LDL macrophages foam cells

monocyte accumulation GF, cytokine release Ecs, SMCs cytotoxicity

CARDIOVASCULAR SYSTEM

Page 35: Cvs 2

4. Smooth muscle cells:SMCs migration proliferation & ECM deposition

↓Fatty streak fibrofatty atheromatous plaquePDGF, TGF-a, FGFFoam cellsECM (collagen) depositedSMCs apoptosis

CARDIOVASCULAR SYSTEM

Page 36: Cvs 2

MORPHOLOGY:

Fatty streak:

children aortas

coronaries in adolescents

multiple, flat yellow dots

coalesce to streaks

lipid laden foam cells

CARDIOVASCULAR SYSTEM

Page 37: Cvs 2

FATTY STREAK

Page 38: Cvs 2

Atheromatous plaque:elastic & muscular arterieslower abdominal aorta > thoracic aortaostia and branchessymptomatic AS disease

MI heart attackcerebral infarction strokeperipheral vascular gangrene

CARDIOVASCULAR SYSTEM

Page 39: Cvs 2

aorta > coronaries > popliteal > internal carotid > circle of willis

white – white yellow

variable size

eccentric lesions

obstruction of lumen

CARDIOVASCULAR SYSTEM

Page 40: Cvs 2

Mild, Moderate, Severe AS

Page 41: Cvs 2
Page 42: Cvs 2

Components:

1. Cells:

SMCs

macrophages

T lymphocytes

other leukocytes

CARDIOVASCULAR SYSTEM

Page 43: Cvs 2

2. ECM:

collagen

elastic fibers

proteoglycans

3. lipids:

intracellular

extracellular

CARDIOVASCULAR SYSTEM

Page 44: Cvs 2
Page 45: Cvs 2
Page 46: Cvs 2
Page 47: Cvs 2

Plaque change:enlargementulceration/erosionrupturethrombosisembolismhaemorrhagecalcificationaneurysmal dilation

CARDIOVASCULAR SYSTEM

Page 48: Cvs 2
Page 49: Cvs 2
Page 50: Cvs 2

ARTEIOLOSCLEROSIS:Small Bv, arterioles

Hyaline homogenous pink hyaline thickeningnarrowed lumenelderlyHypertensionBenign nephrosclerosis

CARDIOVASCULAR SYSTEM

Page 51: Cvs 2
Page 52: Cvs 2

microangiopathy of DM

Hyperplastic:

malignant HTN

onion skin

concentric, laminated thickening

SMCs & thickened BM

necrotizing arteriolitis

CARDIOVASCULAR SYSTEM

Page 53: Cvs 2
Page 54: Cvs 2

ANEURYSM:

Localized abnormal dilation of a blood vessel or

heart.

True aneurysm

all layers of Bv or heart

False aneurysm (pseudoaneurysm)

extravascular hematoma

CARDIOVASCULAR SYSTEM

Page 55: Cvs 2
Page 56: Cvs 2
Page 57: Cvs 2

Causes:AtherosclerosisCystic medial degenerationTrauma (A-V aneurysms)Congenital defects (berry aneurysms)Infections (mycotic)Vasculitis

CARDIOVASCULAR SYSTEM

Page 58: Cvs 2

Types:SaccularFusiform

Sites:Abdominal aortacommon iliac AArch of aortadescending thoracic aorta

CARDIOVASCULAR SYSTEM

Page 59: Cvs 2
Page 60: Cvs 2
Page 61: Cvs 2
Page 62: Cvs 2

Mycotic aneurysm:

septic embolus

direct extension

bacteraemia

CARDIOVASCULAR SYSTEM

Page 63: Cvs 2

ABDOMINAL AORTIC ANEURYSMS(AAA):Atherosclerosis> 50 yrs> malesgenetic susceptibility ↓ connective tissue

strengthMMP TIMPHTN

CARDIOVASCULAR SYSTEM

Page 64: Cvs 2

Morphology:

B/W bifurcation & renal arteries

saccular/fusiform

variable size

thromboemboli

occlusion of ostia

CARDIOVASCULAR SYSTEM

Page 65: Cvs 2
Page 66: Cvs 2

Variants:

Inflammatory AAA

dense periaortic fibrosis

inflammatory cells (lymphos, plasma cells)

Mycotic AAA

AS AAA + bacteremia

Salmonella gastroentritis

CARDIOVASCULAR SYSTEM

Page 67: Cvs 2

Complications:

Rupture

Obstruction adjacent BV

Embolism

Compression adjacent structures

Abdominal mass

CARDIOVASCULAR SYSTEM

Page 68: Cvs 2

SYPHILITIC ANEURYSM:

Leutic

Obliterative endartritis

vasa vasorum

lymphocytes & plasma cells

syphilitic aortitis

CARDIOVASCULAR SYSTEM

Page 69: Cvs 2

weakening of media

tree barking

aortic valve insufficiency

cor bovinum (cow’s heart)

CARDIOVASCULAR SYSTEM

Page 70: Cvs 2

AORTIC DISSECTION

“Dissection of blood between & along laminar planes of media”

1. HTN 40-60 yrs males

2. CT defects young age

3. Iatrogenic

4. Pregnancy

CARDIOVASCULAR SYSTEM

Page 71: Cvs 2

CARDIOVASCULAR SYSTEM

Page 72: Cvs 2

Morphology:

intimal tear

10 cm from aortic valve

transverse / oblique

sharp edges

extension

dissecting hematoma

CARDIOVASCULAR SYSTEM

Page 73: Cvs 2

CARDIOVASCULAR SYSTEM

Page 74: Cvs 2
Page 75: Cvs 2

rupture out pericardial, pleural, peritonealdouble barreled aortacystic medial degeneration cystic medial necrosis

Classification:Type A: Proximal

III

Type B: Distal

CARDIOVASCULAR SYSTEM

Page 76: Cvs 2

CARDIOVASCULAR SYSTEM

Page 77: Cvs 2

VASCULITIS:

Inflammation of vessel wall.

Infectious

direct invasion

immune mechanism

Immune mediated

CARDIOVASCULAR SYSTEM

Page 78: Cvs 2

CARDIOVASCULAR SYSTEM

Page 79: Cvs 2

PATHOGENETIC CLASSIFICATION:Direct infection:

Bacterial, Rickettsial, Spirochetal, Fungal, ViralImmunologic:

immune complex mediatedANCA mediatedDirect antibody mediatedCell mediated

Unknown

CARDIOVASCULAR SYSTEM

Page 80: Cvs 2

CLASSIFICATION ACCORDING TO SIZE:

Large vessel

Medium sized vessel

Small vessel

CARDIOVASCULAR SYSTEM

Page 81: Cvs 2

CARDIOVASCULAR SYSTEM

Page 82: Cvs 2

TYPES:

Granulomatous

granuloma formation

giant cells

Necrotizing

fibrinoid necrosis

fibrous thickening of wall

CARDIOVASCULAR SYSTEM

Page 83: Cvs 2
Page 84: Cvs 2
Page 85: Cvs 2
Page 86: Cvs 2
Page 87: Cvs 2

TUMORS OF BLOOD VESSELS:Vascular malformations

HamartomasReactive vascular proliferations

Bacillary angiomatosisBenign tumors:Blood/lymphatic filled channelsTransudateEndothelial lining without atypia

CARDIOVASCULAR SYSTEM

Page 88: Cvs 2

Malignant tumors :

More solid & cellular

Atypia ++

Mitotic figures

No well formed vascular channels

CARDIOVASCULAR SYSTEM

Page 89: Cvs 2

Benign:Hemangioma

capillarycavernouspyogenic granuloma

Lymphangiomasimplecavernous

CARDIOVASCULAR SYSTEM

Page 90: Cvs 2

Glomus tumor

Vascular ectasias

nevus flamus

spider telangiectasia

hereditary haemorrhagic telangiectasia

reactive vascular proliferations

bacillary angiomatosis

CARDIOVASCULAR SYSTEM

Page 91: Cvs 2

Intermediate grade tumors:

Kaposi sarcoma

Hemangioendothelioma

Malignant neoplasms:

Angiosarcoma

Hemangiopericytoma

CARDIOVASCULAR SYSTEM

Page 92: Cvs 2

HEMANGIOMA:

localized

superficial

head & neck

internal

angiomatosis

7% of benign childhood tumors

CARDIOVASCULAR SYSTEM

Page 93: Cvs 2

Capillary hemangioma:Gross:

skin, sub-cutaneous tissue, mucus membranesliver, spleen, kidneysvariable sizebright red – blueelevatedintact epithelium

CARDIOVASCULAR SYSTEM

Page 94: Cvs 2
Page 95: Cvs 2
Page 96: Cvs 2

Histologically:lobulatedunencapsulatedclosely packedthin walled capillariesflat endotheliumscanty stromathrombosed lumen

CARDIOVASCULAR SYSTEM

Page 97: Cvs 2
Page 98: Cvs 2
Page 99: Cvs 2

Strawberry hemangioma

newborns

grows and regresses

CARDIOVASCULAR SYSTEM

Page 100: Cvs 2
Page 101: Cvs 2

Cavernous hemangioma:

less common

larger

less well circumscribed

deep structures

locally destructive

CARDIOVASCULAR SYSTEM

Page 102: Cvs 2

Gross:red-bluespongy1-2 cm

Histologically:sharply definednot encapsulatedlarge cavernous vascular spaces

CARDIOVASCULAR SYSTEM

Page 103: Cvs 2

blood filled

scanty stroma

intravascular thrombosis

dystrophic calcification

CARDIOVASCULAR SYSTEM

Page 104: Cvs 2
Page 105: Cvs 2
Page 106: Cvs 2
Page 107: Cvs 2

GLOMUS TUMOR:Benign PainfulGlomus bodyDistal part of digitsSmall, elevated, roundRed-blue firm nodulesBranching vascular channelsAggregates/nests of glomus cells around BV

IOVCARDASCULAR SYSTEM

Page 108: Cvs 2
Page 109: Cvs 2
Page 110: Cvs 2

KAPOSI’S SARCOMA:1. Chronic/Classic/European

Kaposi in 1872older mennot associated with HIVhomosexual menmultiple red – purple skin plaques/nodulesarms & legs

CARDIOVASCULAR SYSTEM

Page 111: Cvs 2

gradual spread

asymptomatic & localized

visceral involvement 10%

2. Lymphadenopathic/African/Endemic:

Bantu children of SA

lymphadenopathy

aggressive

CARDIOVASCULAR SYSTEM

Page 112: Cvs 2

3. Transplant associated/immunosuppression associated:

months-years post transplant

aggressive

lymph node, mucosa, viscera

internal involvement fatal

CARDIOVASCULAR SYSTEM

Page 113: Cvs 2

4. AIDS associated:1/3rd AIDS patientswide dissemination

Morphology:3 stages: Patch

pink-red-purplesingle/multiple macules

CARDIOVASCULAR SYSTEM

Page 114: Cvs 2

distal lower extremitiesdilated, irregular angulated BVendothelial cell linedlymphocytes, plasma cells, macrophages

Plaqueslarger, violaceousraiseddermal dilated vascular channels

CARDIOVASCULAR SYSTEM

Page 115: Cvs 2

plump spindle cell lining

perivascular aggregates of spindle cells

red cells

hemosiderin laden macrophages

lymphocytes, plasma cells

pink hyaline globules in spindle cells

mitotic figures

CARDIOVASCULAR SYSTEM

Page 116: Cvs 2

Nodulesneoplasticsheets of plump spindle cellsproliferate in dermis, sub-cutaneous tissueslit like spaces & small Bvhemosiderin , macrophagesmitotic figuresLN + viscera

CARDIOVASCULAR SYSTEM

Page 117: Cvs 2

Pathogenesis:

HHV-8/KSHV latent infection

immunosuppression ↓ apoptosis endothelial cells (p53)

↑ cell proliferation

CARDIOVASCULAR SYSTEM

Page 118: Cvs 2
Page 119: Cvs 2
Page 120: Cvs 2
Page 121: Cvs 2
Page 122: Cvs 2
Page 123: Cvs 2

DISEASES OF HEART:

Mechanisms of Cardiac dysfunction:

1. Pump failure

2. Outflow obstruction

3. Regurgitant flow

4. Conduction defects

5. Disruption of circulation

CARDIOVASCULAR SYSTEM

Page 124: Cvs 2

Genetics environment

CARDIOVASCULAR SYSTEM

Page 125: Cvs 2
Page 126: Cvs 2

HEART FAILURE (Congestive heart failure):Forward failure (↓ CO) orBackward failure (venous damming) orBothMyocardial hypertrophy:

permanent cellsno hyperplasiahypertrophy

CARDIOVASCULAR SYSTEM

Page 127: Cvs 2
Page 128: Cvs 2
Page 129: Cvs 2
Page 130: Cvs 2
Page 131: Cvs 2

CARDIAC HYPERTROPHY:

Pressure overload hypertrophy

concentric hypertrophy

HTN, aortic stenosis

thickened left vent wall ↓ chamber

sarcomere deposition parallel

cross sectional area of myocyte ↑ not length

CARDIOVASCULAR SYSTEM

Page 132: Cvs 2

Volume overload hypertrophy:

ventricular dilation

wall thickness chamber diameter

sarcomere deposition parallel & vertical

↑ thickness & length

CARDIOVASCULAR SYSTEM

Page 133: Cvs 2
Page 134: Cvs 2
Page 135: Cvs 2
Page 136: Cvs 2

“ Structure of hypertrophied heart is not normal. It is a tight balance between adaptation and deleterious alterations ( ↓ capillary-to-myocyte ratio, ↑ fibrous tissue & synthesis of abnormal proteins). Thus sustained cardiac hypertrophy evolves into cardiac failure.”

CARDIOVASCULAR SYSTEM

Page 137: Cvs 2

Molecular & cellular changes that initially mediate enhanced function later contributes to heart failure.

Physiologic hypertrophy.

Pathologic hypertrophy.

CARDIOVASCULAR SYSTEM

Page 138: Cvs 2

Left sided heart failure:

Causes:

IHD

HTN

Aortic, mitral valvular disease

non ischemic MC disease

CARDIOVASCULAR SYSTEM

Page 139: Cvs 2

Morphology:

Evidence of cause

enlarged size

↑ left vent wall thickness

secondary effects on atria

CARDIOVASCULAR SYSTEM

Page 140: Cvs 2

Extracardiac effects:

1. Pulmonary congestion & edema

heavy, wet lungs

interstitial transudate Kerly’s B lines

widening of alveolar septa

edema in alveolar spaces

heart failure cells

CARDIOVASCULAR SYSTEM

Page 141: Cvs 2
Page 142: Cvs 2
Page 143: Cvs 2
Page 144: Cvs 2

dyspnea

orthopnea

paroxysmal nocturnal dyspnea

2. Kidneys

↓ renal perfusion

pre renal azotemia

CARDIOVASCULAR SYSTEM

Page 145: Cvs 2

3. Brainhypoxic encephalopathy

Right sided heart failure:Causes

left sided heart failurechronic severe pulmonary HTN

(cor pulmonale)

CARDIOVASCULAR SYSTEM

Page 146: Cvs 2

Morphologyengorgement of systemic & portal venous systems

1. Liver & portal system:congestive hepatomegalycentrilobular necrosiscardiac sclerosis / cardiac cirrhosiscongestive splenomegaly

CARDIOVASCULAR SYSTEM

Page 147: Cvs 2
Page 148: Cvs 2
Page 149: Cvs 2

2. Kidneys:severely affectedpronounced azotemia

3. Brain:venous congestion & hypoxia

4. Pleural & pericardial space:effusions

5. Subcutaneous tissues:edema (pedal)anasarca

CARDIOVASCULAR SYSTEM

Page 150: Cvs 2

Heart disease:

Congenital heart disease

Ischemic heart disease

Hypertensive heart disease

Valvular heart disease

Myocardial disease

CARDIOVASCULAR SYSTEM

Page 151: Cvs 2

ISCHEMIC HEART DISEASE (IHD):

↓ oxygen supply

↓ nutrient supply

↓ removal of waste

90% coronary atherosclerosis CAD

CARDIOVASCULAR SYSTEM

Page 152: Cvs 2
Page 153: Cvs 2

4 clinical manifestations of IHD:

1. Myocardial Infarction

2. Angina Pectoris

3. Chronic IHD

4. Sudden cardiac death

Acute Coronary Syndromes (1, 2, 4)

CARDIOVASCULAR SYSTEM

Page 154: Cvs 2

Leading cause of death

50% reduction in IHD related mortality in USA

Prevention

Early diagnosis (advanced facilities)

Therapeutic intervention (effective, safer)

CARDIOVASCULAR SYSTEM

Page 155: Cvs 2

CARDIOVASCULAR SYSTEM

Page 156: Cvs 2

PATHOGENESIS:

Demand supply

↑↑ ↓↓

↓ ISCHEMIA

CARDIOVASCULAR SYSTEM

Page 157: Cvs 2

AS obstruction fixed / stable obstruction

plaque change ↓

↓ ↓

ISCHEMIA

75% obstruction symptomatic on ↑ demand

90% obstruction symptomatic at rest

CARDIOVASCULAR SYSTEM

Page 158: Cvs 2
Page 159: Cvs 2

Role of acute plaque change:Rupture/ulcerationErosion/fissuring thrombosisHaemorrhageIntrinsic influences

structure & composition of plaqueextrinsic influences

blood pressure, Plt reactivity

CARDIOVASCULAR SYSTEM

Page 160: Cvs 2

Structure of plaqueVulnerable plaque

↑ foam cells↑ extracellular lipidsthin fibrous capsfew SMCsinflammatory cell clusters

Junction of fibrous cap & adjacent endothelium

CARDIOVASCULAR SYSTEM

Page 161: Cvs 2
Page 162: Cvs 2

Collagen deposition degradationmetalloproteinases by macrophages

Adrenergic stimulation systemic HTN & plt reactivity stress on plaques

Early morningEmotional stress

CARDIOVASCULAR SYSTEM

Page 163: Cvs 2

Role of inflammation:

All stages of AS

Macrophages & T lymphocytes

IL-1, IL-6, TNF, INF g

Metalloproteinses weaken plaque

Inflammation destabilizes plaque

CARDIOVASCULAR SYSTEM

Page 164: Cvs 2

Role of coronary thrombus:

Partial / total acute coronary syndromes

Mural branch thrombus embolize

Microinfarcts

Role of vasoconstriction:

Potentiate plaque change

CARDIOVASCULAR SYSTEM

Page 165: Cvs 2

ANGINA PECTORIS:

“A symptom complex of IHD cahracaterized by recurrent attacks of substernal/precordial chest discomfort caused by transient MC ischemia that falls short of inducing infarction.”

CARDIOVASCULAR SYSTEM

Page 166: Cvs 2
Page 167: Cvs 2
Page 168: Cvs 2

TYPES:

Stable / typical

Unstable / crescendo

Prinzmetal / variant

CARDIOVASCULAR SYSTEM

Page 169: Cvs 2

STABLE ANGINA:

Chronic stenosing atherosclerosis ↓ coronary perfusion

↑ demand MC ischemia

Triggered by exercise, stress

Relieved by rest, nitroglycerine

CARDIOVASCULAR SYSTEM

Page 170: Cvs 2

UNSTABLE ANGINA:

Progressively ↑ing frequency

At rest

Prolonged duration

Disruption of stable atheroma thrombosis

Embolization, vasospasm

CARDIOVASCULAR SYSTEM

Page 171: Cvs 2

CARDIOVASCULAR SYSTEM

Page 172: Cvs 2

PRINZMETAL ANGINA:

Uncommon

Episodic

At rest

Coronary vasospasm

Responds to vasodilators

CARDIOVASCULAR SYSTEM

Page 173: Cvs 2

CARDIOVASCULAR SYSTEM

Page 174: Cvs 2

MYOCARDIAL INFARCTION:

“Heart attack”

Death of cardiac muscle due to ischemia.

Transmural infarction

Subendocardial infarction

CARDIOVASCULAR SYSTEM

Page 175: Cvs 2

CARDIOVASCULAR SYSTEMTRANSMURAL SUBENDOCARDIAL

Full thickness of MC Inner 1/3rd or half

AS plaque change thrombosis

As plaque change thrombosis recanalized

Hypotension / shock on chronic stenosing AS

Limited to area of supply Can extend beyond

Page 176: Cvs 2

Incidence & risk factors:

Any age

Risk factors of AS

Pathogenesis:

Coronary artery occlusion

Acute plaque change thrombosis VC

↑ size of thrombus complete occlusion

CARDIOVASCULAR SYSTEM

Page 177: Cvs 2

10% MI not associated with AS plaque change. Vasospasm Emboli (paradoxical emboli) Unexplained (vasculitis, Hg defects, amyloid)

CARDIOVASCULAR SYSTEM

Page 178: Cvs 2

Myocardial response:

Biochemical

Functional

Morphological

CARDIOVASCULAR SYSTEM

Page 179: Cvs 2

CARDIOVASCULAR SYSTEM FEATURE TIME

ATP depletion Seconds

Loss of contractility < 2 min

ATP reduced to 50%

10%

10 min

40 min

Irreversible cell injury 20 – 40 min

Microvascular injury > 1 hr

Page 180: Cvs 2

Early identificationReperfusion

30 min reversible injuryMC ischemia subendocardial zoneWavefront progression transmural Necrosis within 6 hrsGrossly visible after 12 hrs

CARDIOVASCULAR SYSTEM

Page 181: Cvs 2

Factors influencing MI:1. Site, size, rate of development of AS2. Size of vascular bed3. Duration4. Mc demands5. Collateral circulation6. Coronary artery spasm7. BP, HR, cardiac rhythm

CARDIOVASCULAR SYSTEM

Page 182: Cvs 2

CARDIOVASCULAR SYSTEMMorphology:

Left ventricle > right ventricle

Rim of subendocardium preserved

LAD 40 – 50% Ant wall left vent, apex, ant septum

RCA 30 – 40% Inf-post wall lt vent, post septum, post right vent

LCA 15 – 20% Lat wall left vent

Page 183: Cvs 2

CARDIOVASCULAR SYSTEMTIME GROSS MICROSCOPIC

0 – ½ hr ----- myofibril relaxation, swelling of mitochondria

½ - 4 hr ----- Wavy fibers

4 – 12 h Occ dark mottling Coag necrosis, edema, hge

12-24 h Dark mottling Necrosis, pyknosis,myocyte eosinophilia, contraction bands, neutrophils

Page 184: Cvs 2

CARDIOVASCULAR SYSTEM1 -3 days Mottling + yellow

centreLoss of nuclei & striations, PMNs ++

3 – 7 days Red border, yellow tan center

Disintegration, phagocytosis

7 – 10 days

Max yellow soft center, red borders

Phagocytosis ++, granulation tissue at margins

10-14 days

Red-gray depressed

Granulation tissue ++, collagen +

2 – 8 wks Grey white scar ↑ collagen, ↓ cellularity

> 2 month Complete scar Dense collagenous scar

Page 185: Cvs 2
Page 186: Cvs 2

1 day MI showing contraction band

Page 187: Cvs 2

1-2 days

Page 188: Cvs 2
Page 189: Cvs 2
Page 190: Cvs 2
Page 191: Cvs 2

3-4 day

Page 192: Cvs 2

1-2 wks

Page 193: Cvs 2

Healing infarct

Page 194: Cvs 2

Reperfusion injury/Myocardial stunning:

Restoration of coronary flow reperfusion

Ischemia variable effects on MC

Reperfusion salvage

damage O2 free radicals

haemorrhage

apoptosis

CARDIOVASCULAR SYSTEM

Page 195: Cvs 2

Persistence of biochemical & functional changes

in reperfused MC stunned MC

CARDIAC ENZYMES:

CPK (MM, MB, BB)

AST

LDH

Troponins

CARDIOVASCULAR SYSTEM

Page 196: Cvs 2
Page 197: Cvs 2
Page 198: Cvs 2

Complication of MI:1. Contractile dysfunction crdiogenic shock2. Arrhythmias3. MC rupture cardiac rupture syndrome4. Pericarditis5. Right ventricular infarction6. Extension7. Mural thrombosis8. Ventricular aneurysm9. Papillary muscle dysfunction10. Progressive late heart failure

CARDIOVASCULAR SYSTEM

Page 199: Cvs 2
Page 200: Cvs 2
Page 201: Cvs 2

CARDIOVASCULAR SYSTEM

Page 202: Cvs 2

CARDIOVASCULAR SYSTEM

Page 203: Cvs 2
Page 204: Cvs 2

CARDIOVASCULAR SYSTEM

Page 205: Cvs 2

BE GENTLE WITH THE EARTH

Page 206: Cvs 2

RHEUMATIC FEVER & HEART DISEASE

“A multisystem inflammatory disease having an

acute onset with underlying immune

pathogenesis occurring few weeks after streptococcal pharyngitis.”

Acute Rheumatic carditis Rheumatic heart disease

CARDIOVASCULAR SYSTEM

Page 207: Cvs 2

Children (5-15 yrs)

10 days – 6 weeks

Arthritis & carditis

Relapsing course

Chronic Rheumatic Carditis

CARDIOVASCULAR SYSTEM

Page 208: Cvs 2

PATHOGENESIS:

Group A Streptococcal throat infection

Antibodies M component streptococci

Cross react glycoprotein antigens

Heart, joints, skin, brain

CARDIOVASCULAR SYSTEM

Page 209: Cvs 2

CARDIOVASCULAR SYSTEM

Page 210: Cvs 2
Page 211: Cvs 2
Page 212: Cvs 2

RF characterized by:

Migratory polyarthritis

Carditis

Subcutaneous nodules

Erythema marginatum

Sydenham chorea

CARDIOVASCULAR SYSTEM

Page 213: Cvs 2

CARDIOVASCULAR SYSTEM

Page 214: Cvs 2
Page 215: Cvs 2

MORPHOLOGY:Acute RF Focal inflammatory lesions Aschoff bodies

swollen eosinophilic collagenT lymphocytes, plasma cellsmacrophages Anitschkow cells

abundant cytoplasmcentral round/oval nucleuscentral slender chromatin caterpillar cellsAschoff giant cells

CARDIOVASCULAR SYSTEM

Page 216: Cvs 2
Page 217: Cvs 2
Page 218: Cvs 2

Pancarditis

Bread & Butter Pericarditis

Myocarditis Perivascular Aschoff nodules

Verrucae/vegetations on valves

fibrinoid necrosis

MacCallum Plaques (left atrium)

CARDIOVASCULAR SYSTEM

Page 219: Cvs 2
Page 220: Cvs 2
Page 221: Cvs 2
Page 222: Cvs 2
Page 223: Cvs 2

Chronic Rheumatic Heart Disease:Organization of acute inflammationLeaflet thickeningCommissural fusionThickened, short & fused cordae tendinaeProgressive fibrosisButtonhole deformityFish mouth appearance

CARDIOVASCULAR SYSTEM

Page 224: Cvs 2
Page 225: Cvs 2

Mitral stenosis:

99% cases due to RHD

RHD 65% - 70 % alone

with aortic valve 25%

Atrial dilation mural thrombosis

Pulmonary vascular changes

CARDIOVASCULAR SYSTEM

Page 226: Cvs 2

INFECTIVE ENDOCARDITIS:Severe infection of endocardium and heart

valvesVegetations (thrombotic debris &

microorganisms)Clinical classification:

AcuteSubacute

CARDIOVASCULAR SYSTEM

Page 227: Cvs 2

CARDIOVASCULAR SYSTEM ACUTE IE SUBACUTE IE

Healthy valves Diseased/prosthesis

Highly virulent organisms Low virulence

Acute & severe Insidious

50% mortality Recovery common

Destructive necrotizing Less destructive

Page 228: Cvs 2

PATHOGENESIS:Valvular diseases (RHD, prolapse, degenerative

calcific stenosis)Immune compromised statesAetiology:

Strep viridans (50-60%) defective valvesStaph Aureus (10-20%) healthy.defective

I/V drug abusers

CARDIOVASCULAR SYSTEM

Page 229: Cvs 2

HACEK group

Staph epidermidis prosthetic valve IE

gram –ive bacilli

fungi

culture negative

CARDIOVASCULAR SYSTEM

Page 230: Cvs 2

MORPHOLOGY:

Bulky, Friable, Destructive vegetations

Single/multiple

Fibrin & inflammatory cells

Aortic & mitral valves

Ring abscess

CARDIOVASCULAR SYSTEM

Page 231: Cvs 2
Page 232: Cvs 2
Page 233: Cvs 2

Fungal Endocarditis

larger vegetations

Systemic emboli Septic infarcts

SIE granulation tissue at base

LIBMAN-SACKS ENDOCARDITIS:

Endocarditis of SLE

CARDIOVASCULAR SYSTEM

Page 234: Cvs 2

Dukes Diagnostic Criteria for IE:Pathologic:

+ culturesvegetation histologyintracardiac abscess

Clinical:Major:

+ blood cultureEchocardiographic findings, valvular defects

CARDIOVASCULAR SYSTEM

Page 235: Cvs 2

Minor:

predisposing heart lesion

vascular lesions

immunologic phenomena

cultures

echocardiographic

CARDIOVASCULAR SYSTEM

Page 236: Cvs 2

CARDIOMYOPATHIES:

Intrinsic disease of myocardium:

Myocarditis

Immunologic

Systemic metabolic

Muscular dystrophies

Genetic abnormalities

CARDIOVASCULAR SYSTEM

Page 237: Cvs 2

Heart disease resulting from a primary

abnormality in the myocardium Cardiomyopathy

Dilated cardiomyopathy (DCM) Hypertrophic cardiomyopathy (HCM) Restrictive cardiomyopathy (RCM)

CARDIOVASCULAR SYSTEM

Page 238: Cvs 2

CARDIOVASCULAR SYSTEMDCM HCM RCM

Commonest 90% Least common

Systolic dysfunction

Diastolic dysfunction

Diastolic dysfunction

Dilated heart obstructive CM Compliance ↓

Hypertrophied Hypertrophy ++ Normal

Hypocontracting hypercontracting Normal

Heavy, large, flabby

Banana-like cavity left vent

-----

Thin walls Thick septum++ ----------

Page 239: Cvs 2

CARDIOVASCULAR SYSTEM

Dilated No dilation -----

Thrombosis Mural palque ------

Hypertrophied cells/attenuated

Hypertrophy ++

Myofiberdisarray

------

fibrosis Fibrosis Patchy/diffuse fibrosis +

Page 240: Cvs 2
Page 241: Cvs 2
Page 242: Cvs 2
Page 243: Cvs 2

Causes:

Idiopathic

Genetic abnormalities in MC metabolism

Myocarditis

Alcohol

Pregnancy associated

Genetic influences

CARDIOVASCULAR SYSTEM

Page 244: Cvs 2

DCM HCMGenetic(30-40%) 100% genetic

↓ Non genetic ↓↓ ↓ ↓

Force generation ↓ force generation ↓ DCM phenotype HCM phenotype

↓ ↓heart failure, sudden death, atrial fib, stroke

CARDIOVASCULAR SYSTEM

Page 245: Cvs 2

MYOCARDITIS:Infections:

Viruses (coxsackie, ECHO, influenza, HIV)ChlamydiaRickettsiaeBacteriaFungiProtozoaHelminths

CARDIOVASCULAR SYSTEM

Page 246: Cvs 2

Immune mediatedpost viralpost streptococcal (RF)SLEDrugsTransplant rejection

Unknownsarcoidosisgiant cell myeloma

CARDIOVASCULAR SYSTEM

Page 247: Cvs 2

Morphology:

Hypertrophy, dilated, flabby

Diffuse/patchy

Mottled

Mural thrombi

Interstitial inflammatory infiltrate (mononuclear)

Focal necrosis

CARDIOVASCULAR SYSTEM

Page 248: Cvs 2

Hypersensitivty MC perivascular lymphocytes

Macrophages, eosinophils

Giant cell myocarditis giant cells, lympho, eos

plasma cells, macrophages

CARDIOVASCULAR SYSTEM

Page 249: Cvs 2

PERICARDITIS:

Acute

Serous

Fibrinous

Purulent

Haemorrhagic

Caseous

CARDIOVASCULAR SYSTEM

Page 250: Cvs 2
Page 251: Cvs 2
Page 252: Cvs 2
Page 253: Cvs 2
Page 254: Cvs 2

Chronic:Adhesive mediatinopericarditisConstrictive pericarditis

CAUSES:Infectious (viruses, bacteria, TB, fungi)Immunologic (RF, SLE, scleroderma, post MI,(dresslers syndrome) drugsMiscellaneous (MI, uremia, cardiac surgery, neoplasia,

trauma, radiation)

CARDIOVASCULAR SYSTEM

Page 255: Cvs 2

TUMORS OF HEART:Primary (rare)Secondary/metastatic (5% dying patients)Benign:

MyxomaFibromaLipomaPapillary fibroelastomaRhabdomyomas

Malignant:Angiosarcoma & other SAs

CARDIOVASCULAR SYSTEM

Page 256: Cvs 2

MYXOMA:Commonest primary tumor90% in atria Atrial MyxomaLeft : right = 4 : 1SingleNear fossa ovalis<1 – 10 cmSessile / pedunculated wrecking ball effect embolize

CARDIOVASCULAR SYSTEM

Page 257: Cvs 2
Page 258: Cvs 2

Hard – soft gelatinous

Stellate cells (lepidic cells)

Endothelial cells

SMCs

Undifferentiated cells

Mucopolysaccharide ground substance ++

Endothelial covering

CARDIOVASCULAR SYSTEM

Page 259: Cvs 2
Page 260: Cvs 2
Page 261: Cvs 2

HYPERTENSIVE HEART DISEASE (HHD)

An adaptive response

Systemic HTN left HHD

Pulmonary HTN right HHD

Systemic HHD:

1. Left ventricular hypertrophy

2. Evidence of HTN

CARDIOVASCULAR SYSTEM

Page 262: Cvs 2

Pressure overload = afterload concentricHypertrophy↑ weightDefective diastolic fillingLeft atrial dilation↑ transverse diameter of myocyteVariation in cell sizeInterstitial fibrosis

CARDIOVASCULAR SYSTEM

Page 263: Cvs 2
Page 264: Cvs 2

Pulmonary HHD:

COR PULMONALE

Right vent hypertrophy & dilation

Acute/chronic

Massive pulmonary embolism acute PHHD

Prolonged pulmonary overload chronic PHHD

CARDIOVASCULAR SYSTEM

Page 265: Cvs 2

Acute:

Ventricle dilated ++

NO HYPERTROPHY

Ovoid shaped vent cavity

Chronic:

hypertrophy

CARDIOVASCULAR SYSTEM

Page 266: Cvs 2

CONGENITAL HEART DISEASE:Ventricular septal defectsAtrial septal defectsPulmonary stenosisPatent ductus arteriosisCoarctation of aortaAV septal defectsTransposition of great arteriesTruncus arteriosisTricuspid atresia

CARDIOVASCULAR SYSTEM

Page 267: Cvs 2

TETROLOGY OF FALLOT:

1. VSD

2. Sub-pulmonary stenosis

3. Overriding aorta over pulmonary stenosis

4. Right ventricular hypertrophy

CARDIOVASCULAR SYSTEM

Page 268: Cvs 2
Page 269: Cvs 2

HYPERTENSIVE VASCULAR DISEASE:

HTN carries potential risk of

cardiac hypertrophy heart failure

coronary artery disease IHD

CVA

Genetic

Environmental factors

CARDIOVASCULAR SYSTEM

Page 270: Cvs 2

CAUSES:Essential HTNSecondary HTN:

RenalAGNCRDpolycystic diseaserenal artery stenosisrenal vasculitisRenin producing tumors

CARDIOVASCULAR SYSTEM

Page 271: Cvs 2

Endocrine:Adrenocortical hyperfunctionexogenous hoemonespheochromocytomaacromegalyhypothyroidismhyperthyroidismpregnancy induced

CARDIOVASCULAR SYSTEM

Page 272: Cvs 2

Cardiovascular:

coarctation aorta

polyartritis nodosa

↑ intravascular volume

↑ CO

rigidity of aorta

CARDIOVASCULAR SYSTEM

Page 273: Cvs 2

Neurologic:

psychogenic

↑ intracranial pressure

sleep apnea

acute stress

CARDIOVASCULAR SYSTEM

Page 274: Cvs 2

PATHOGENESIS:

BP = CO x PR

CARDIOVASCULAR SYSTEM

Page 275: Cvs 2
Page 276: Cvs 2
Page 277: Cvs 2
Page 278: Cvs 2

CARDIOVASCULAR SYSTEMThe mediocre teacher tells.The good teacher explains.

The superior teacher demonstrates.The great teacher inspires.

                                                                             (William Arthur Ward)